Trial
NCT05180474
GEN1047 for Solid Tumors - First in Human (FIH) Trial
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Genmab
Collaborators
—
Condition
Breast Cancer, Breast Neoplasms
Intervention
GEN1047 is a bispecific antibody that induces T-cell mediated cytotoxicity of B7H4-positive tumor cells.
Why stopped
The Sponsor has made a strategic decision to stop the development of GEN1047.
Provenance
Dataset: 2026-07-24 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-23